TrialClinical cancer research : an official journal of the American Association for Cancer Research2008

Phase I/II study of G3139 (Bcl-2 antisense oligonucleotide) in combination with doxorubicin and docetaxel in breast cancer.

Stacy L Moulder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.